CADTH announces new members to its health technology expert review panel

10 September 2014 - Dr. Brian O’Rourke, President and CEO of CADTH, today announced the appointment of three new core members ...

Read more →

Recommendations made by the PBAC - March 2015

The recommendations from the March 2015 Pharmaceutical Benefits Advisory Committee meeting are now available on the PBS website. All outcomes have been entered in ...

Read more →

NICE responds to Telegraph article on value based assessment

[:content [\9 \space \J \a \n \u \a \r \y \space \2 \0 \1 \4 \space \- \  \S \i \r \space \A \n \d \r \e \w \space \D \i \l \l \o \n \, \space \C \h \i \e \f \space \E \x \e \c \u \t \i \v \e \space \o \f \space \N \I \C \E \, \space \s \a \i \d \: \  \\ \" \W \e \space \h \a \v \e \space \n \o \space \i \n \t \e \n \t \i \o \n \space \o \f \space \i \n \t \r \o \d \u \c \i \n \g \space \a \space \c \h \a \n \g \e \space \t \o \space \o \u \r " ..."]]
Read more →

The outcomes from the October 2013 CDEC meeting have been added to MAESTrO Canada

[:content [\C \D \E \C \space \m \a \d \e \space \f \o \u \r \space \r \e \c \o \m \m \e \n \d \a \t \i \o \n \s \: \space \J \e \n \t \a \d \u \e \t \o \space \( \l \i \n \a \g \l \i \p \t \i \n \space \w \i \t \h \space \m \e \t \f \o \r \m \i \n \space \h \y \d \r \o \c \h \l \o \r \i \d \e \) \, \space \F \y \c \o \m \p \a \space \( \p \e \r \a \m \p \a \n \e \l \) \space \& \space \E \d \a \r \b \i \space \( \a \z \i \l \s \a \r \t \a \n \space \m \e \d \o \x \o \m \i \l \space \p \o \t \a \s \s \i \u \m \) \space \w \e \r \e \space \a \l \l \space \r \e \c \o \m \m \e \n \d \e \d \, \space \w \h \e \r \e \a \s " ..."]]
Read more →

Behind the headlines - Champagne perks of NHS watchdog

[:content [\1 \1 \space \J \a \n \u \a \r \y \space \2 \0 \1 \4 \space \- \  \A \c \c \u \s \a \t \i \o \n \s \space \t \h \a \t \space \o \f \f \i \c \i \a \l \s \space \a \t \space \t \h \e \space \N \a \t \i \o \n \a \l \space \I \n \s \t \i \t \u \t \e \space \f \o \r \space \H \e \a \l \t \h \space \a \n \d \space \C \a \r \e \space \E \x \c \e \l \l \e \n \c \e \space \h \a \v \e \space \u \s \e \d \space \c \r \e \d \i \t \space \c \a \r \d \s \space \o \n " ..."]]
Read more →

Public opinion divided over UK drugs spend

A new survey conducted for the ABPI shows that public opinion on whether the UK spends enough money on medicines ...

Read more →

NICE recommends new treatment option for multiple sclerosis

[:content [\6 \space \D \e \c \e \m \b \e \r \space \2 \0 \1 \3 \space \- \  \I \n \space \f \i \n \a \l \space \d \r \a \f \t \space \g \u \i \d \a \n \c \e \space \t \h \e \space \N \I \C \E \space \h \a \s \  \r \e \c \o \m \m \e \n \d \space \t \h \e \space \u \s \e \space \o \f \space \G \e \n \z \y \m \e \' \s \space \d \r \u \g \space \f \o \r \space \m \u \l \t \i \p \l \e \space \s \c \l \e \r \o \s \i \s \space \A \u \b \a \g \i \o \space \( \t \e \r \i \f \l \u \n \o \m \i \d \e \) \. \  \N \I \C \E " ..."]]
Read more →

Drug companies give their tax affairs a clean bill of health ahead of Senate grilling

Multi-national drug companies are presenting a united front ahead of their appearance at the Senate's corporate tax avoidance inquiry, insisting ...

Read more →

May 2015 tender notification

PHARMAC has resolved to award tenders for Sole Subsidised Supply Status and Hospital Supply Status for some products included in ...

Read more →

Feedback on draft RFP for medicines for rare disorders

PHARMAC is pleased to announce the outcome of the consultation on the draft request for proposals for supply of medicines ...

Read more →

Novartis chief backs shake-up in drug pricing

Pharmaceutical companies must move towards new pricing models based on outcomes for patients if Europe’s cash-strapped health systems are to ...

Read more →

Health system deserves keener scalpel than GP co-payments

The Abbott government is weathering a storm of opposition to its proposed budget items that would see the introduction of ...

Read more →

Schedule of Pharmaceutical Benefits update - 1 August 2014

The 1 August 2014 issue of the Schedule of Pharmaceutical Benefits is not available. The new Schedule contains a number of ...

Read more →

Dasabuvir in hepatitis C: indication of added benefit in certain patients

The drug dasabuvir (trade name Exviera) has been available since January 2015 for the treatment of adults with chronic hepatitis ...

Read more →

Access to Medicines Working Group Communique - 7 August 2014

The second meeting of the reinvigorated AMWG occurred on 7 August 2014.  ...

Read more →